Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)

Bardoxolone methyl significantly increases estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD). However, the phase 3 study, Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: the Occurrence of Renal Events (BEACON...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kidney international reports 2020-06, Vol.5 (6), p.879-890
Hauptverfasser:	Nangaku, Masaomi, Kanda, Hironori, Takama, Hirotaka, Ichikawa, Tomohiro, Hase, Hiroki, Akizawa, Tadao
Format:	Artikel
Sprache:	eng
Schlagworte:	bardoxolone methyl chronic kidney disease Clinical Research diabetic kidney disease glomerular filtration rate heart failure inulin clearance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!